Literature DB >> 6791752

Fatal bone-marrow suppression associated with captopril.

M E Safar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6791752      PMCID： PMC1506858          DOI： 10.1136/bmj.283.6294.791-b

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Successful reintroduction of captopril following neutropenia.

Authors:  C R Edwards; P Drury; A Penketh; S A Damluji
Journal:  Lancet       Date:  1981-03-28       Impact factor: 79.321

2.  Lupus-type illness associated with labetalol.

Authors:  I D Griffiths; J Richardson
Journal:  Br Med J       Date:  1979-08-25

3.  [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].

Authors:  P Zech; N Pozet; J Sassard; M Vincent
Journal:  Nouv Presse Med       Date:  1980-03-29
  3 in total
  3 in total

Review 1.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.